Unleashing T cell anti-tumor immunity: new potential for 5-Nonloxytryptamine as an agent mediating MHC-I upregulation in tumors CONCLUSIONS: This study demonstrates novel therapeutic opportunities for augmenting immune responses in poorly immunogenic … ← Psychosis Endophenotypes: A Gene-Set-Specific Polygenic Risk Score Analysis Superdiffusion-like behavior in zero-temperature coarsening of the [Formula: see text] Ising model →